Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in HFrEF patients with CardioMEMS
NCT04570865Phase 4Unknown
- Sponsor
- Scripps Health
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin, sponsored by Scripps Health. Status: unknown.
02
Drugs
dapagliflozin
Beyond the preview
Go deeper on NCT04570865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04570865.